PharmiWeb13m
Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options
Prior Phase 3 studies showed positive benefits in increasing unstimulated whole saliva secretionAinos aims to complete all regulatory approvals for the study in Q4 2024SAN DIEGO, CA / ACCESSWIRE / ...
PharmiWeb17m
Apprentice.io Announces New AI-Powered Capabilities at European Pharma Event and Offers a Free Trial of Its Tempo Manufacturing Cloud
Tempo Manufacturing Cloud Seamless processing through every layer of your manufacturing ecosystem in one platform by combining historically distributed systems ? Manufacturing Execution System (MES), ...
PharmiWeb42m
Avant Brands Expands Global Footprint with BLK MKT(TM) Launch in Australia
KELOWNA, BC and MELBOURNE, AUSTRALIA / ACCESSWIRE / September 23, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading Canadian producer of award-winning, ...
PharmiWeb1h
Science & Humans Proudly Welcomes Renowned Healthcare Leader Karim "Matt" Nassar as Chief Growth Officer
MISSISSAUGA, ON / ACCESSWIRE / September 23, 2024 / Science & Humans (S&H), Canada's leading platform for hormone health, is excited to announce the appointment of Karim (Matt) Nassar as Chief Growth ...
PharmiWeb1h
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
New System Enhances Surgical Efficiency and Provides Versatile Solutions for Complex Spine ProceduresBELGRADE, MT / ACCESSWIRE / September 23, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), ...
PharmiWeb1h
Pentixapharm Holding AG Sets Price Range for Planned IPO
IPOPentixapharm Holding AG Sets Price Range for Planned IPO 23.09.2024 / 12:15 CET/CESTThe issuer is solely responsible for the content of this announcement.ADVERTISEMENTNOT FOR DISTRIBUTION OR ...
PharmiWeb3h
Just – Evotec Biologics opens cutting-edge biologics facility - J.POD® Toulouse, France (EU)
Evotec Biologics, the biologics segment of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: ...
PharmiWeb6h
Angle PLC Announces Exclusive agreement for DNA NGS panel
ANGLE ANNOUNCES NEXT GENERATION SEQUENCING ASSAY AGREEMENT WITH NUPROBEOption for exclusive licence to highly sensitive NGS assay for use with CTCs and dual analysis of CTCs with ctDNACombining the ...
PharmiWeb7h
Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement
Miscellaneous23-Sep-2024 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Announces $2 ...